Latest Insider Transactions at Cme Group Inc. (CME)
This section provides a real-time view of insider transactions for Cme Group Inc. (CME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CME GROUP INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CME GROUP INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 31
2022
|
Daniel R Glickman Director |
SELL
Open market or private sale
|
Direct |
500
-3.31%
|
$98,000
$196.39 P/Share
|
|
Aug 16
2022
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Bona fide gift
|
Indirect |
1,637
+9.86%
|
-
|
|
Aug 16
2022
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Bona fide gift
|
Direct |
1,637
-15.2%
|
-
|
|
Aug 15
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
4,901
-12.88%
|
$994,903
$203.88 P/Share
|
|
Jun 27
2022
|
William R Shepard Director |
BUY
Small Acquisition
|
Direct |
10
+0.47%
|
$2,110
$211.06 P/Share
|
|
Jun 27
2022
|
Howard J Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,146
+2.52%
|
$239,514
$209.44 P/Share
|
|
Jun 27
2022
|
Daniel G Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+20.99%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Robert J Tierney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+6.42%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Deborah J Lucas Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+17.37%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Charles P Carey Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,146
+11.5%
|
$239,514
$209.44 P/Share
|
|
Jun 27
2022
|
Ana Dutra Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+8.81%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Bryan T Durkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+1.0%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Patrick J Mulchrone Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+2.56%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Terry L Savage Director |
BUY
Grant, award, or other acquisition
|
Indirect |
693
+3.5%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Patrick W Maloney Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+25.67%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Larry G Gerdes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,146
+2.92%
|
$239,514
$209.44 P/Share
|
|
Jun 27
2022
|
Elizabeth A Cook Director |
BUY
Grant, award, or other acquisition
|
Indirect |
693
+3.44%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Michael G. Dennis Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct |
693
+25.58%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Dennis Suskind Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+15.23%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
William R Shepard Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,146
+0.57%
|
$239,514
$209.44 P/Share
|
|
Jun 27
2022
|
Timothy S. Bitsberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+6.01%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Rahael Seifu Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+25.7%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Daniel R Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
844
+5.29%
|
$176,396
$209.44 P/Share
|
|
Jun 27
2022
|
William W Hobert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,146
+1.36%
|
$239,514
$209.44 P/Share
|
|
Jun 27
2022
|
Phyllis M Lockett Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+20.99%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Martin J Gepsman Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+2.78%
|
$144,837
$209.44 P/Share
|
|
Jun 27
2022
|
Dennis Chookaszian Director |
BUY
Grant, award, or other acquisition
|
Direct |
693
+14.44%
|
$144,837
$209.44 P/Share
|
|
Mar 25
2022
|
William R Shepard Director |
BUY
Small Acquisition
|
Direct |
8
+0.38%
|
$1,960
$245.59 P/Share
|
|
Mar 16
2022
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-0.55%
|
$17,666
$242.01 P/Share
|
|
Mar 15
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Bona fide gift
|
Direct |
280
-0.67%
|
-
|
|
Mar 15
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Payment of exercise price or tax liability
|
Direct |
881
-2.07%
|
$204,392
$232.0 P/Share
|
|
Mar 15
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
BUY
Grant, award, or other acquisition
|
Direct |
2,542
+5.63%
|
$589,744
$232.0 P/Share
|
|
Mar 15
2022
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
749
-2.53%
|
$173,768
$232.0 P/Share
|
|
Mar 15
2022
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,243
+7.04%
|
$520,376
$232.0 P/Share
|
|
Mar 15
2022
|
Suzanne Sprague Sr MD Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
1,242
+14.93%
|
$288,144
$232.0 P/Share
|
|
Mar 15
2022
|
Suzanne Sprague Sr MD Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
66
-2.5%
|
$15,312
$232.0 P/Share
|
|
Mar 15
2022
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-2.27%
|
$215,528
$232.0 P/Share
|
|
Mar 15
2022
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,542
+5.85%
|
$589,744
$232.0 P/Share
|
|
Mar 15
2022
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
103
-0.77%
|
$23,896
$232.0 P/Share
|
|
Mar 15
2022
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
349
+2.54%
|
$80,968
$232.0 P/Share
|
|
Mar 15
2022
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Grant, award, or other acquisition
|
Direct |
1,246
+15.39%
|
$289,072
$232.0 P/Share
|
|
Mar 15
2022
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-2.95%
|
$16,936
$232.0 P/Share
|
|
Mar 15
2022
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+4.91%
|
$532,440
$232.0 P/Share
|
|
Mar 15
2022
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-0.37%
|
$16,936
$232.0 P/Share
|
|
Mar 15
2022
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,638
-5.05%
|
$1,076,016
$232.0 P/Share
|
|
Mar 15
2022
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,468
+10.24%
|
$2,428,576
$232.0 P/Share
|
|
Mar 15
2022
|
John W. Pietrowicz Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,331
-2.48%
|
$308,792
$232.0 P/Share
|
|
Mar 15
2022
|
John W. Pietrowicz Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,290
+5.78%
|
$763,280
$232.0 P/Share
|
|
Mar 15
2022
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
905
-7.75%
|
$209,960
$232.0 P/Share
|
|
Mar 15
2022
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
2,542
+17.88%
|
$589,744
$232.0 P/Share
|